1. Israel Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Holdco Nuvo Group D.G Ltd. Warrants

Holdco Nuvo Group D.G Ltd. Warrants

NUVOW
Holdco Nuvo Group D.G Ltd. WarrantsUS flagNASDAQ
0.01
USD
+0.00
- -
82,965.00Market Cap
2021 Y
2022 Y
2023 Y
Revenue per Share
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
Dividend per Share
- -
- -
- -
Book Value per Share
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Operating Margin (%)
- -
- -
-9,450.57
Depreciation Expense
- -
- -
- -
Net Income, GAAP
-35
-21
-34
Effective Tax Rate (%)
- -
- -
- -
Profit Margin (%)
- -
- -
-19,122.16
Working Capital
-27
-39
-29
LT Debt
- -
- -
1
Total Equity
-26
-39
-67
Return on Invested Capital (%)
- -
- -
- -
Return on Capital (%)
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
74.37%
Free Cash Flow
- -
- -
9.25%
Net Income, GAAP
- -
- -
62.75%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Robert Maurice Powell Jr.
Sector
Healthcare
Industry
Medical - Devices
Address
Israel
IPO Date
Jun 30, 2023
CIK
0001990145
Similar Companies
Wellstar International, Inc. (WLSI)
Xiangyu Medical Co.,Ltd (688626.SS)
Alphatec Holdings, Inc. (ATEC)
Quipt Home Medical Corp. (QIPT)
Nanomix Corporation (NNMX)
HeartSciences Inc. (HSCS)
Business
Holdco Nuvo Group D.G Ltd. develops and markets medical devices focused on remote pregnancy monitoring, primarily through its INVU platform that combines proprietary wireless sensory bands for self-administered data collection on maternal and fetal heart rates and uterine activity with AI-powered cloud software for personalized health reports and obstetrician access; the platform supports nonstress tests from the 32nd week of pregnancy through labor onset at home or in clinics. The company operates in Israel, the United States, and internationally, targeting expectant mothers and healthcare providers in the maternal-fetal medicine segment. Founded in 2006 and headquartered in Tel Aviv, Israel, at Alon Tower 1, it employs 44 people and maintains collaborations such as with Royal Philips and Charité – Universitätsmedizin Berlin. In May 2024, the company changed its name from Nuvo Group Ltd. and completed a business combination with LAMF Global Ventures Corp. I to become publicly listed on Nasdaq under the NUVO ticker, now trading OTC as NUVOQ with associated warrants NUVOW exercisable through January 2029; on August 22, 2024, it filed a voluntary Chapter 11 reorganization petition in the U.S. Bankruptcy Court for the District of Delaware. Robert Maurice Powell serves as CEO and director, overseeing operations amid these restructuring efforts.